Severe irreversible bilateral hearing loss after bortezomib (VELCADE®) therapy in a multiple myeloma (MM) patient

被引:14
|
作者
Engelhardt, M
Müller, AMS
Maier, W
Wäsch, R
机构
[1] Univ Med Ctr, Dept Hematol & Oncol, D-79106 Freiburg, Germany
[2] Univ Freiburg, Dept Otolaryngol, D-7800 Freiburg, Germany
关键词
D O I
10.1038/sj.leu.2403723
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
引用
收藏
页码:869 / 870
页数:2
相关论文
共 50 条
  • [41] Nonspecific Interstitial Pneumonitis after Bortezomib and Thalidomide Treatment in a Multiple Myeloma Patient
    Kang, Wonseok
    Kim, Jin Seok
    Cho, Sang Ho
    Kim, Sung Kyu
    Chang, Joon
    Park, Moo Suk
    YONSEI MEDICAL JOURNAL, 2010, 51 (03) : 448 - 450
  • [42] A Phase II Study of Bortezomib (Velcade®), Cyclophosphamide (Cytoxan®), Thalidomide (Thalomid®) and Dexamethasone as First-Line Therapy for Multiple Myeloma
    Bensinger, William
    Jagannath, Sundar
    Vescio, Robert
    Camacho, Elber S.
    Wolf, Jeffrey Lee
    Irwin, David H.
    Capo, Gerardo, III
    McKinley, Marti
    Potts, Phyllis
    Vesole, David H.
    Mazumder, Amitabha
    Esseltine, Dixie-Lee
    Becker, Pamela
    Crowley, John
    Durie, Brian G. M.
    BLOOD, 2008, 112 (11) : 42 - 42
  • [43] Multiple myeloma (MM) polyneuropathy before and after initial chemotherapy with single-agent bortezomib
    Oaklander, Anne Louise
    Richardson, Paul G.
    Briemberg, Hannah
    Anderson, Kenneth C.
    Wen, Patrick
    Chan-Khan, Asher A.
    Schlossman, Robert L.
    Munshi, Nikhil C.
    Heffner, L. Thompson
    Hassoun, Hani
    Avigan, David E.
    Amato, Anthony
    ANNALS OF NEUROLOGY, 2006, 60 : S94 - S94
  • [44] Marked improvement of platelet transfusion refractoriness after bortezomib therapy in multiple myeloma
    Hirokazu Miki
    Shuji Ozaki
    Osamu Tanaka
    Etsuko Lee
    Tomomi Takimoto
    Hirofumi Watanabe
    Shiro Fujii
    Shingen Nakamura
    Kumiko Kagawa
    Kyoko Takeuchi
    Ken-ichiro Yata
    Masahiro Abe
    Shoji Kagami
    Toshio Matsumoto
    International Journal of Hematology, 2009, 89 : 223 - 226
  • [45] Severe pulmonary complications in Japanese patients after bortezomib treatment for refractory multiple myeloma
    Miyakoshi, S
    Kami, M
    Yuji, K
    Matsumura, T
    Takatoku, M
    Sasaki, M
    Narimatsu, H
    Fujii, T
    Kawabata, M
    Taniguchi, S
    Ozawa, K
    Oshimi, K
    BLOOD, 2006, 107 (09) : 3492 - 3494
  • [46] Marked improvement of platelet transfusion refractoriness after bortezomib therapy in multiple myeloma
    Miki, Hirokazu
    Ozaki, Shuji
    Tanaka, Osamu
    Lee, Etsuko
    Takimoto, Tomomi
    Watanabe, Hirofumi
    Fujii, Shiro
    Nakamura, Shingen
    Kagawa, Kumiko
    Takeuchi, Kyoko
    Yata, Ken-ichiro
    Abe, Masahiro
    Kagami, Shoji
    Matsumoto, Toshio
    INTERNATIONAL JOURNAL OF HEMATOLOGY, 2009, 89 (02) : 223 - 226
  • [47] Severe pulmonary complications after bortezomib treatment for multiple myeloma: An unrecognized pulmonary vasculitis?
    Pitini, Vincenzo
    Arrigo, Carmela
    Altavilla, Giuseppe
    Naro, Claudia
    LEUKEMIA RESEARCH, 2007, 31 (07) : 1027 - 1028
  • [48] Thalidomide/dexamethasone (TD), bortezomib (Velcade)/thalidomide/dexamethasone (VTD) and VBMCP/VBAD/Velcade as induction therapy prior to high-dose therapy/autologous stem cell transplantation in multiple myeloma
    Rosinol, L.
    Cibeira, M. T.
    Martinez, J.
    Mateos, M. V.
    Oriol, A.
    Terol, M. J.
    Garcia-Larana, J.
    Hernandez, D.
    de la Rubia, J.
    Sureda, A.
    Besalduch, J.
    Palomera, L.
    Gonzalez, Y.
    Echebeste, M. A.
    Diaz-Mediavilla, J.
    de Arriba, F.
    Alegre, A.
    Hernandez, M.
    Lahuerta, J. J.
    Miguel, J. F. San
    Blade, J.
    BONE MARROW TRANSPLANTATION, 2010, 45 : S18 - S18
  • [49] Hearing improvement after tumor removal in a vestibular schwannoma patient with severe hearing loss
    Y. Inoue
    K. Ogawa
    J. Kanzaki
    European Archives of Oto-Rhino-Laryngology, 2003, 260 : 487 - 489
  • [50] Hearing improvement after tumor removal in a vestibular schwannoma patient with severe hearing loss
    Inoue, Y
    Ogawa, K
    Kanzaki, J
    EUROPEAN ARCHIVES OF OTO-RHINO-LARYNGOLOGY, 2003, 260 (09) : 487 - 489